FOX04-DRI
Also known as: FOXO4-DRI, Proxofim, FOXO4-D-Retro-Inverso
Senolytic peptide that disrupts the FOXO4-p53 interaction to selectively clear senescent (worn-out) cells. Animal evidence only, no human trials yet. Excluded from the PK simulator because no verified human data exists.
Pharmacokinetics
Research only · no verified human PK. The values below are class estimates, not measured data, and this peptide is excluded from the Lab serum-level simulator.
- Half-life
- 3 days
- Time to peak
- 4 hours
- Bioavailability
- 70%
- Onset
- 24 hours
- Dosing interval
- 48h
Administration
- Primary routes
- SubQ
- Category
- Longevity & Anti-Aging
Safety Flags
- Contraindicated in cancer history
Storage
- · Requires refrigeration (2–8°C)
- · Temperature sensitive — minimise room-temp exposure
Used in 1 outcome protocol
Simulate FOX04-DRI
Pinned.life runs a 1-compartment Bateman pharmacokinetic simulation against 38 peptides in real time. Build a stack, see serum-level curves, get warned about peak overlaps and drug-peptide interactions.